Dr. David Michael Tehrani, MD

Dr. Tehrani practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Dr. Tehrani's NPI, 1851771158, was assigned on June 2, 2015. Dr. Tehrani graduated from UC Irvine School of Medicine in 2014. Dr. Tehrani holds California license A160798.

Dr. Tehrani's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Dr. Tehrani's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. Dr. Tehrani is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Tehrani to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tehrani practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Tehrani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Tehrani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Tehrani's licenses on file in 2 states: California and Illinois.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, chronic hypertension, coronary artery disease, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Tehrani treats.

CMS data shows 6,708 Medicare services from Dr. Tehrani across 41 procedure codes in 2024, for 2,014 Medicare patients. Medicare paid $486,483 for them.

CMS counts 2,014 Medicare patients who saw Dr. Tehrani in 2024. The largest group is 65 to 74, with 761 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tehrani's median patient age at 65, with 48% women.

In 2024, Dr. Tehrani wrote 3,926 Medicare Part D claims for 633 patients. 83% of them were for generic drugs. CMS names the drug for 3,750 of them, across 37 drugs with 11 or more claims each, at $729,657 in total drug cost. In 2023, CMS named 378 claims across 13 drugs.

Dr. Tehrani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tehrani as offering telehealth. CMS counts 81 procedures of coronary angioplasty and stenting by Dr. Tehrani, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Tehrani, published from 2009 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Coronary Angiography, Heart-Assist Devices and Cardiac Catheterization. Dr. Tehrani has published most often in Catheter Cardiovasc Interv. Dr. Tehrani's most frequent co-authors are Arnold Hoo Seto, MD, Gabriel T. Sayer, MD and Nir Uriel, MD.

CMS Open Payments shows 140 general payments to Dr. Tehrani from 19 drug and device companies from 2016 to 2025. Grants make up the largest share, 40% of the total. Medtronic, Inc. paid the most, $9,699.

Dmand AI lists 1 award for Dr. Tehrani, most recently Inductee in 2014.

Dr. Tehrani graduated from UC Irvine School of Medicine in 2014.

Dr. Tehrani is in network with 8 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.